Статті в журналах з теми "PHARMACOPHORE MODELING"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-50 статей у журналах для дослідження на тему "PHARMACOPHORE MODELING".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.
Kutlushina, Alina, Aigul Khakimova, Timur Madzhidov, and Pavel Polishchuk. "Ligand-Based Pharmacophore Modeling Using Novel 3D Pharmacophore Signatures." Molecules 23, no. 12 (November 27, 2018): 3094. http://dx.doi.org/10.3390/molecules23123094.
Повний текст джерелаMortier, Jérémie, Pratik Dhakal, and Andrea Volkamer. "Truly Target-Focused Pharmacophore Modeling: A Novel Tool for Mapping Intermolecular Surfaces." Molecules 23, no. 8 (August 6, 2018): 1959. http://dx.doi.org/10.3390/molecules23081959.
Повний текст джерелаMadzhidov, Timur I., Assima Rakhimbekova, Alina Kutlushuna, and Pavel Polishchuk. "Probabilistic Approach for Virtual Screening Based on Multiple Pharmacophores." Molecules 25, no. 2 (January 17, 2020): 385. http://dx.doi.org/10.3390/molecules25020385.
Повний текст джерелаKumar, Saurav, Deepika Deepika, and Vikas Kumar. "Pharmacophore Modeling Using Machine Learning for Screening the Blood–Brain Barrier Permeation of Xenobiotics." International Journal of Environmental Research and Public Health 19, no. 20 (October 18, 2022): 13471. http://dx.doi.org/10.3390/ijerph192013471.
Повний текст джерелаAFFI, Sopi Thomas, Doh SORO, Souleymane COULIBALY, Bibata KONATE, and Nahossé ZIAO. "Modeling anticancer pharmacophore based on inhibition of HDAC7." SDRP Journal of Computational Chemistry & Molecular Modeling 5, no. 3 (2021): 657–63. http://dx.doi.org/10.25177/jccmm.5.3.ra.10776.
Повний текст джерелаMansi, Iman A., Mahmoud A. Al-Sha'er, Nizar M. Mhaidat, Mutasem O. Taha, and Rand Shahin. "Investigation of Binding Characteristics of Phosphoinositide-dependent Kinase-1 (PDK1) Co-crystallized Ligands Through Virtual Pharmacophore Modeling Leading to Novel Anti-PDK1 Hits." Medicinal Chemistry 16, no. 7 (November 6, 2020): 860–80. http://dx.doi.org/10.2174/1573406415666190724131048.
Повний текст джерелаKadu, Nilesh S., and Atul V. Ingle. "Three-Dimensional Pharmacophore Modeling of Betulonic Acid Derivatives as a Strong Inhibitor of Human Coronavirus-229E Replication." International Journal of Science and Healthcare Research 6, no. 2 (July 1, 2021): 356–61. http://dx.doi.org/10.52403/ijshr.20210462.
Повний текст джерелаMendez, Nixon, and Md Afroz Alam. "Structural Features of Quercetin Derivatives by Using Pharmaco-phore Modeling Approach." Open Pharmaceutical Sciences Journal 3, no. 1 (June 6, 2016): 79–98. http://dx.doi.org/10.2174/1874844901603010079.
Повний текст джерелаThai, Khac-Minh, Trieu-Du Ngo, Thanh-Dao Tran, and Minh-Tri Le. "Pharmacophore Modeling for Antitargets." Current Topics in Medicinal Chemistry 13, no. 9 (May 1, 2013): 1002–14. http://dx.doi.org/10.2174/1568026611313090004.
Повний текст джерелаGuner, Osman, and J. Bowen. "Pharmacophore Modeling for ADME." Current Topics in Medicinal Chemistry 13, no. 11 (June 1, 2013): 1327–42. http://dx.doi.org/10.2174/15680266113139990037.
Повний текст джерелаEngels, Maida, Se Balaji B, Divakar S., and Geetha G. "LIGAND BASED PHARMACOPHORE MODELING, VIRTUAL SCREENING AND MOLECULAR DOCKING STUDIES TO DESIGN NOVEL PANCREATIC LIPASE INHIBITORS." International Journal of Pharmacy and Pharmaceutical Sciences 9, no. 4 (February 14, 2017): 48. http://dx.doi.org/10.22159/ijpps.2017v9i4.16392.
Повний текст джерелаde Groot, Marcel J., and Sean Ekins. "Pharmacophore modeling of cytochromes P450." Advanced Drug Delivery Reviews 54, no. 3 (March 2002): 367–83. http://dx.doi.org/10.1016/s0169-409x(02)00009-1.
Повний текст джерелаHariono, Maywan, and Habibah A. Wahab. "Pharmacophore Modeling of N1-alkyltheobromine as Histamine-H1 Receptor Antagonist." International Journal of Modeling and Optimization 5, no. 2 (April 2015): 98–103. http://dx.doi.org/10.7763/ijmo.2015.v5.443.
Повний текст джерелаLu, Xin, Hongyu Yang, Yao Chen, Qi Li, Si-yu He, Xueyang Jiang, Feng Feng, Wei Qu, and Haopeng Sun. "The Development of Pharmacophore Modeling: Generation and Recent Applications in Drug Discovery." Current Pharmaceutical Design 24, no. 29 (December 8, 2018): 3424–39. http://dx.doi.org/10.2174/1381612824666180810162944.
Повний текст джерелаShirbhate E., Divya, V. K. Patel, P. Patel, R. Veerasamy, T. Jawaid, M. Kamal, and H. Rajak. "LEAD IDENTIFICATION OF HYDROXAMATE DERIVATIVE AS SELECTIVE HDAC2 INHIBITOR USING COMPUTATIONAL APPROACHES." INDIAN DRUGS 57, no. 07 (October 8, 2020): 26–39. http://dx.doi.org/10.53879/id.57.07.12042.
Повний текст джерелаKumar, Sivakumar Prasanth, and Prakash Chandra Jha. "Multi-Pharmacophore Modeling of Caspase-3 Inhibitors using Crystal, Dock and Flexible Conformation Schemes." Combinatorial Chemistry & High Throughput Screening 21, no. 1 (March 20, 2018): 26–40. http://dx.doi.org/10.2174/1386207321666180102114917.
Повний текст джерелаYamakawa, Yuko, Kazuharu Furutani, Atsushi Inanobe, Yuko Ohno, and Yoshihisa Kurachi. "Pharmacophore modeling for hERG channel facilitation." Biochemical and Biophysical Research Communications 418, no. 1 (February 2012): 161–66. http://dx.doi.org/10.1016/j.bbrc.2011.12.153.
Повний текст джерелаNoonan, Theresa, Katrin Denzinger, Valerij Talagayev, Yu Chen, Kristina Puls, Clemens Alexander Wolf, Sijie Liu, Trung Ngoc Nguyen, and Gerhard Wolber. "Mind the Gap—Deciphering GPCR Pharmacology Using 3D Pharmacophores and Artificial Intelligence." Pharmaceuticals 15, no. 11 (October 22, 2022): 1304. http://dx.doi.org/10.3390/ph15111304.
Повний текст джерелаChidambaram, Kumarappan. "Identification of BACE-1 Inhibitors against Alzheimer’s Disease through E-Pharmacophore-Based Virtual Screening and Molecular Dynamics Simulation Studies: An Insilco Approach." Life 13, no. 4 (April 5, 2023): 952. http://dx.doi.org/10.3390/life13040952.
Повний текст джерелаSugumar, Shobana. "VIRTUAL SCREENING, PHARMACOPHORE MODELING, AND QUANTITATIVE STRUCTURE ACTIVITY RELATIONSHIP STUDIES ON HISTAMINE 4 RECEPTOR." Asian Journal of Pharmaceutical and Clinical Research 10, no. 12 (December 1, 2017): 150. http://dx.doi.org/10.22159/ajpcr.2017.v10i12.19991.
Повний текст джерелаJb, Sheema, and Waheeta Hopper. "ENERGY-BASED PHARMACOPHORE MODELING, VIRTUAL SCREENING, AND MOLECULAR DYNAMICS TO IDENTIFY POTENTIAL INHIBITORS FOR GLYCOGEN SYNTHASE KINASE 3 BETA." Asian Journal of Pharmaceutical and Clinical Research 11, no. 2 (February 1, 2018): 181. http://dx.doi.org/10.22159/ajpcr.2018.v11i2.22962.
Повний текст джерелаZou, Jun, Huan-Zhang Xie, Sheng-Yong Yang, Jin-Juan Chen, Ji-Xia Ren, and Yu-Quan Wei. "Towards more accurate pharmacophore modeling: Multicomplex-based comprehensive pharmacophore map and most-frequent-feature pharmacophore model of CDK2." Journal of Molecular Graphics and Modelling 27, no. 4 (November 2008): 430–38. http://dx.doi.org/10.1016/j.jmgm.2008.07.004.
Повний текст джерелаDong, Xialan, Jerry O. Ebalunode, Sheng-Yong Yang, and Weifan Zheng. "Receptor-Based Pharmacophore and Pharmacophore Key Descriptors for Virtual Screening and QSAR Modeling." Current Computer Aided-Drug Design 7, no. 3 (September 1, 2011): 181–89. http://dx.doi.org/10.2174/157340911796504332.
Повний текст джерелаTodkar, S. S., and A. H. Hoshmani. "DESIGN OF POTENTIAL CYCLOOXYGENASE INHIBITORS USING PHARMACOPHORE OPTIMIZATION BY MOLECULAR MODELING STUDIES." INDIAN DRUGS 52, no. 12 (December 28, 2015): 16–22. http://dx.doi.org/10.53879/id.52.12.10154.
Повний текст джерелаMansi, Iman, Mahmoud A. Al-Sha'er, Nizar Mhaidat, and Mutasem Taha. "Ligand Based Pharmacophore Modeling Followed by Biological Screening Lead to Discovery of Novel PDK1 Inhibitors as Anticancer Agents." Anti-Cancer Agents in Medicinal Chemistry 20, no. 4 (May 15, 2020): 476–85. http://dx.doi.org/10.2174/1871520620666191224110600.
Повний текст джерелаVadlakonda, Rajashekar, Sreenivas Enaganti, and Raghunandan Nerella. "INSILICO DISCOVERY OF HUMAN AURORA B KINASE INHIBITORS BY MOLECULAR DOCKING, PHARMACOPHORE VALIDATION AND ADMET STUDIES." Asian Journal of Pharmaceutical and Clinical Research 10, no. 2 (February 1, 2017): 165. http://dx.doi.org/10.22159/ajpcr.2017.v10i2.14974.
Повний текст джерелаAbdElmoniem, Nihal, Marwa H. Abdallah, Rua M. Mukhtar, Fatima Moutasim, Ahmed Rafie Ahmed, Alaa Edris, Walaa Ibraheem, et al. "Identification of Novel Natural Dual HDAC and Hsp90 Inhibitors for Metastatic TNBC Using e-Pharmacophore Modeling, Molecular Docking, and Molecular Dynamics Studies." Molecules 28, no. 4 (February 13, 2023): 1771. http://dx.doi.org/10.3390/molecules28041771.
Повний текст джерелаDerz, Wiebke, Melita Fleischmann, and Paul W. Elsinghorst. "Guiding Molecularly Imprinted Polymer Design by Pharmacophore Modeling." Molecules 26, no. 16 (August 23, 2021): 5101. http://dx.doi.org/10.3390/molecules26165101.
Повний текст джерелаPu, Yinglan, Shuqun Zhang, Zhe Chang, Yunqin Zhang, Dong Wang, Li Zhang, Yan Li, and Zhili Zuo. "Discovery of new dual binding TNKS inhibitors of Wnt signaling inhibition by pharmacophore modeling, molecular docking and bioassay." Molecular BioSystems 13, no. 2 (2017): 363–70. http://dx.doi.org/10.1039/c6mb00712k.
Повний текст джерелаPeng, Xiu Xiu, Kai Rui Feng та Yu Jie Ren. "Molecular modeling studies of quinazolinone derivatives as novel PI3Kδ selective inhibitors". RSC Advances 7, № 89 (2017): 56344–58. http://dx.doi.org/10.1039/c7ra10870b.
Повний текст джерелаZhang, Chao, Junjie Xiang, Qian Xie, Jing Zhao, Hong Zhang, Erfang Huang, Pangchui Shaw, Xiaoping Liu, and Chun Hu. "Identification of Influenza PAN Endonuclease Inhibitors via 3D-QSAR Modeling and Docking-Based Virtual Screening." Molecules 26, no. 23 (November 25, 2021): 7129. http://dx.doi.org/10.3390/molecules26237129.
Повний текст джерелаSantos, Kelton L. B. dos, Jorddy N. Cruz, Luciane B. Silva, Ryan S. Ramos, Moysés F. A. Neto, Cleison C. Lobato, Sirlene S. B. Ota, et al. "Identification of Novel Chemical Entities for Adenosine Receptor Type 2A Using Molecular Modeling Approaches." Molecules 25, no. 5 (March 10, 2020): 1245. http://dx.doi.org/10.3390/molecules25051245.
Повний текст джерелаAgrawal, Nikhil, Balakumar Chandrasekaran, and Amal Al-Aboudi. "Recent Advances in the In-silico Structure-based and Ligand-based Approaches for the Design and Discovery of Agonists and Antagonists of A2A Adenosine Receptor." Current Pharmaceutical Design 25, no. 7 (June 17, 2019): 774–82. http://dx.doi.org/10.2174/1381612825666190306162006.
Повний текст джерелаDamale, Manoj G., Shahebaaz K. Pathan, Rajesh B. Patil, and Jaiprakash N. Sangshetti. "Pharmacoinformatics approaches to identify potential hits against tetraacyldisaccharide 4′-kinase (LpxK) of Pseudomonas aeruginosa." RSC Advances 10, no. 54 (2020): 32856–74. http://dx.doi.org/10.1039/d0ra06675c.
Повний текст джерелаBrogi, Simone, Maria Kladi, Constantinos Vagias, Panagiota Papazafiri, Vassilios Roussis, and Andrea Tafi. "Pharmacophore Modeling for Qualitative Prediction of Antiestrogenic Activity." Journal of Chemical Information and Modeling 49, no. 11 (October 30, 2009): 2489–97. http://dx.doi.org/10.1021/ci900254b.
Повний текст джерелаXu, Zhejun, Feixiong Cheng, Chenxiao Da, Guixia Liu, and Yun Tang. "Pharmacophore modeling of human adenosine receptor A2A antagonists." Journal of Molecular Modeling 16, no. 12 (March 12, 2010): 1867–76. http://dx.doi.org/10.1007/s00894-010-0690-z.
Повний текст джерелаGhose, Arup K., Vellarkad N. Viswanadhan, and John J. Wendoloski. "THE FUNDAMENTALS OF PHARMACOPHORE MODELING IN COMBINATORIAL CHEMISTRY*." Journal of Receptors and Signal Transduction 21, no. 4 (January 2001): 357–75. http://dx.doi.org/10.1081/rrs-100107923.
Повний текст джерелаMarkt, Patrick, Daniela Schuster, Johannes Kirchmair, Christian Laggner, and Thierry Langer. "Pharmacophore modeling and parallel screening for PPAR ligands." Journal of Computer-Aided Molecular Design 21, no. 10-11 (October 2007): 575–90. http://dx.doi.org/10.1007/s10822-007-9140-0.
Повний текст джерелаBharatham, Kavitha, Nagakumar Bharatham, and Keun Woo Lee. "Pharmacophore modeling for protein tyrosine phosphatase 1B inhibitors." Archives of Pharmacal Research 30, no. 5 (May 2007): 533–42. http://dx.doi.org/10.1007/bf02977644.
Повний текст джерелаFaden, Alan I, Vilen A Movsesyan, Xueliang Fang, and Shaomeng Wang. "Identification of Novel Neuroprotective Agents Using Pharmacophore Modeling." Chemistry & Biodiversity 2, no. 11 (November 2005): 1564–70. http://dx.doi.org/10.1002/cbdv.200590127.
Повний текст джерелаKaushik, Pawan, Sukhbir Lal Khokra, A. C. Rana, and Dhirender Kaushik. "Pharmacophore Modeling and Molecular Docking Studies on Pinus roxburghii as a Target for Diabetes Mellitus." Advances in Bioinformatics 2014 (July 10, 2014): 1–8. http://dx.doi.org/10.1155/2014/903246.
Повний текст джерелаSingh, Karanveer, Manish Sinha, Shruti Kuletha, Baljeet Kaur, Amandeep Kaur, Dinesh K. Tripathi, Kishore K. Srivastava, Vanangamudi Murugesan, Rajala Srikala, and Amrendra K. Chaudhary. "Synthesis, Antitubercular Activity, Molecular Modeling and Docking Studies of Novel Thiazolidin-4-One Linked Dinitrobenzamide Derivatives." Current Bioactive Compounds 16, no. 1 (February 20, 2020): 64–71. http://dx.doi.org/10.2174/1573407214666180720150009.
Повний текст джерелаMathpal, Deepti, Tahani M. Almeleebia, Kholoud M. Alshahrani, Mohammad Y. Alshahrani, Irfan Ahmad, Mohammed Asiri, Mehnaz Kamal, et al. "Identification of 3-((1-(Benzyl(2-hydroxy-2-phenylethyl)amino)-1-oxo-3-phenylpropan-2-yl)carbamoyl)pyrazine-2-carboxylic Acid as a Potential Inhibitor of Non-Nucleosidase Reverse Transcriptase Inhibitors through InSilico Ligand- and Structure-Based Approaches." Molecules 26, no. 17 (August 30, 2021): 5262. http://dx.doi.org/10.3390/molecules26175262.
Повний текст джерелаKandakatla, Naresh, and Geetha Ramakrishnan. "Ligand Based Pharmacophore Modeling and Virtual Screening Studies to Design Novel HDAC2 Inhibitors." Advances in Bioinformatics 2014 (November 26, 2014): 1–11. http://dx.doi.org/10.1155/2014/812148.
Повний текст джерелаMunir, Anum, Shaukat I. Malik, and Khalid A. Malik. "De-Novo Ligand Design against Mutated Huntington Gene by Ligand-based Pharmacophore Modeling Approach." Current Computer-Aided Drug Design 16, no. 2 (March 25, 2020): 134–44. http://dx.doi.org/10.2174/1573409915666181207104437.
Повний текст джерелаKaur, Paramjit, Vikas Sharma, and Vipin Kumar. "Pharmacophore Modelling and 3D-QSAR Studies on -Phenylpyrazinones as Corticotropin-Releasing Factor 1 Receptor Antagonists." International Journal of Medicinal Chemistry 2012 (May 31, 2012): 1–13. http://dx.doi.org/10.1155/2012/452325.
Повний текст джерелаCrisan, Luminita, Daniela Varga, and Liliana Pacureanu. "Pharmacophore Modeling and Docking Study of Pyrazolylaminoquinazoline Derivatives as Highly Potent Fibroblast Growth Factor Receptor Inhibitors2 (FGFR2)." Revista de Chimie 70, no. 3 (April 15, 2019): 790–96. http://dx.doi.org/10.37358/rc.19.3.7008.
Повний текст джерелаSaeed, Mohd, Amir Saeed, Md Jahoor Alam, and Mousa Alreshidi. "Receptor-Based Pharmacophore Modeling in the Search for Natural Products for COVID-19 Mpro." Molecules 26, no. 6 (March 11, 2021): 1549. http://dx.doi.org/10.3390/molecules26061549.
Повний текст джерелаAgrawal, Neetu. "Pharmacophore modeling and 3D-QSAR studies of 2,4-disubstituted pyrimidine derivatives as Janus kinase 3 inhibitors." Journal of Theoretical and Computational Chemistry 19, no. 01 (February 2020): 2050001. http://dx.doi.org/10.1142/s0219633620500017.
Повний текст джерелаNncube, Nomagugu B., Pritika Ramharack, and Mahmoud E. S. Soliman. "Using bioinformatics tools for the discovery of Dengue RNA-dependent RNA polymerase inhibitors." PeerJ 6 (September 25, 2018): e5068. http://dx.doi.org/10.7717/peerj.5068.
Повний текст джерела